OGN

Organon & Co. · Healthcare · Drug Manufacturers - General
$13.34
-0.01 (-0.07%)
Mkt Cap: 3.50B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield28.9%
Dividend YieldN/A
Market Cap3.50B
Volume5.42M
Recent News
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
zacks.com · 2026-05-29
Orogen Reports Strong Q1 2026 Results with 144% Growth in Net Income
accessnewswire.com · 2026-05-26
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
globenewswire.com · 2026-05-21
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
zacks.com · 2026-05-18
Organon to Present New Research on Access and Value at ISPOR 2026
gurufocus.com · 2026-05-15
Organon to Present New Research on Access and Value at ISPOR 2026
businesswire.com · 2026-05-15

Unlock the Full Deep Scan

9 AI agents analyze OGN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →